Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High
- August 18, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Ltd. Share Price Today rose 2.20% to Rs 3,794.95, hit a fresh 52-week high of Rs 3,796.95 and took the company’s market capitalisation to Rs 45,924.32 crore.
Ajanta Pharma Ltd. Share Price moved higher to Rs 3,794.95 on 18 August 2026, up Rs 81.85 or 2.20% from the previous close of Rs 3,713.10, and the stock touched a fresh 52-week high of Rs 3,796.95 in intraday trade. With a market capitalisation of Rs 45,924.32 crore, the move has placed Ajanta Pharma Ltd. Share Price firmly among the stocks in news in the Indian stock market today.
The verified data confirms the price event clearly: the stock opened at Rs 3,713.50, traded between Rs 3,709.10 and Rs 3,796.95, and recorded turnover of Rs 0.64 crore on volume of 1,689 shares. The supplied data establishes the fresh 52-week high, but it does not establish a company-specific catalyst for why the stock is rising today. That distinction matters for investors tracking Ajanta Pharma Ltd. Stock News and Ajanta Pharma Ltd. Share Price Today through a factual lens.
For readers looking for Ajanta Pharma Ltd. Share Price, Ajanta Pharma Ltd. Share Price Today and Ajanta Pharma Ltd. Stock News, the immediate takeaway is straightforward: the stock has printed a new one-year high, the day’s gain is positive, and the market is repricing the counter higher. At the same time, the supplied valuation and profitability figures present a more complex picture, which is where Univest analysis becomes useful. This article reviews the price action, fundamental analysis, sector positioning and peer comparison so investors can see why Ajanta Pharma Ltd. Share Price is attracting attention.
Ajanta Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,794.95 |
| Previous Close | Rs 3,713.1 |
| Today's Change | +Rs 81.85 (+2.2%) |
| Day Open | Rs 3,713.5 |
| Fresh 52-Week High | Rs 3,796.95 |
| Day Low | Rs 3,709.1 |
| Current Volume | 1,689 |
| Turnover | Rs 0.64 crore |
| Market Capitalisation | Rs 45,924.32 crore |
Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,794.95. versus the previous close of Rs 3,713.1, a rise of 2.2%. The stock opened at Rs 3,713.5, reached Rs 3,796.95, touched Rs 3,709.1. Reported volume was 1,689.
Ajanta Pharma Ltd. Share Price Today reflects a clear breakout session, with the stock rising 2.20%, opening near the previous close and then extending higher to a fresh 52-week peak of Rs 3,796.95. The move shows positive intraday price action, though the supplied data does not identify a company-specific trigger.
From a market-structure perspective, Ajanta Pharma Ltd. Share Price began the day at Rs 3,713.50 against a previous close of Rs 3,713.10, indicating a nearly flat start. The stock then moved within a day range of Rs 3,709.10 to Rs 3,796.95 before trading at Rs 3,794.95 around the event timestamp. That places the live price very close to the day’s high and exactly around the zone where the fresh yearly high was registered.
The absolute day gain of Rs 81.85 is significant because it lifted the stock above prior one-year levels and kept it close to the session top. For readers searching Ajanta Pharma Ltd. Share Price Live or Ajanta Pharma Ltd. Share Price Update, that combination of a strong percentage move and a close-to-high trade often explains why a stock enters market movers and top gainers today discussions.
Turnover stood at Rs 0.64 crore, while traded volume was 1,689 shares. The figures confirm active price discovery during the session, even though the supplied data does not include a comparison with average trading volume. In practical terms, Ajanta Pharma Ltd. Share News today is being driven by a verified 52-week high event rather than by an inferred narrative. That makes the next layer of analysis less about speculation and more about whether the supplied fundamentals support the attention Ajanta Pharma Ltd. Share Price is receiving.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 45,924.32 crore |
| P/E Ratio | 170.32x |
| P/B Ratio | 0.42x |
| ROE | -2.89% |
| ROCE | -0.26% |
Ajanta Pharma Ltd. was valued at a P/E ratio of 170.32x, a P/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 170.32x |
| Benchmark Median P/E | 21x |
| Benchmark Average P/E | 49.19x |
| Benchmark P/E Range | 0x to 1,598.54x |
| Company P/B Ratio | 0.42x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 45,924.32 crore |
| Benchmark Median Market Cap | Rs 136.28 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,985.15 | 170.32 | 0.42 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,827.67 | 65.02 | 10.29 | 18.65 | 22.17 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,645.37 | 47.53 | 1.82 | -0.78 | 8.31 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,562.17 | 33.62 | 6.93 | -2.6 | 16.92 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,559.68 | 54.85 | 8.19 | 11.42 | 13.15 |
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 45,924.32 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma Ltd.
Ajanta Pharma Ltd. Share Price is on investor radar for a set of verified reasons visible in the supplied data.
- Fresh 52-week high: the stock touched Rs 3,796.95, marking a new one-year high.
- Positive daily move: Ajanta Pharma Ltd. Share Price Today was up Rs 81.85 or 2.20% from the previous close of Rs 3,713.10.
- Near-session high trade: the current price of Rs 3,794.95 was close to the day’s high, highlighting strong intraday price action.
- Large market capitalisation: at Rs 45,924.32 crore, the company is far larger than the supplied benchmark and peer market-cap figures.
- Valuation contrast: the P/E ratio of 170.32 is high versus the sector median of 21, while the P/B ratio of 0.42 is below the sector median of 1.9.
- Profitability watchpoint: ROE of -2.89% and ROCE of -0.26% are below sector medians, making the fundamental backdrop worth tracking.
About Ajanta Pharma Ltd.
Ajanta Pharma Ltd. (AJANTPHARM) is a listed company in the Healthcare sector. The supplied dataset identifies the stock by its NSE market symbol AJANTPHARM and places it within a peer set that includes pharmaceuticals and healthcare businesses.
Within this article, the verified company context available for Ajanta Pharma Ltd. is limited to its listed identity, sector classification and how the stock compares with sector and peer metrics. That still makes Ajanta Pharma Ltd. Share Price relevant for investors who screen 52 week high stocks, because the company is being tracked within the broader healthcare universe and is now trading at a fresh one-year high.
For practical market tracking, readers should focus on how AJANTPHARM is behaving within the healthcare basket, how its valuation multiples compare with the sector benchmark, and how its market capitalisation stands far above the peer companies supplied in this dataset. Univest uses that combination of price event, market-cap scale and relative valuation to frame Ajanta Pharma Ltd. Stock News in a factual way.
Track Ajanta Pharma Ltd. Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking Ajanta Pharma Ltd. Share Price can use Univest to follow live share price moves, 52-week levels, market capitalisation, valuation ratios and broader stock analysis in one place. For users searching Ajanta Pharma Ltd. Share Price Live or Ajanta Pharma Ltd. Latest News, that helps connect the day’s price action with verified market data.
Univest also helps readers monitor how Ajanta Pharma Ltd. Share Price compares with sector benchmarks and listed peers over time. That is especially useful after a fresh 52-week high, when attention typically shifts from the headline move to whether the valuation, profitability and market-cap context remain aligned with investor expectations. In short, Univest gives a structured way to track Ajanta Pharma Ltd. Share Price Today without turning a market update into a recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Ajanta Pharma Ltd. Share Price Today?
Ans. Ajanta Pharma Ltd. Share Price Today was Rs 3,794.95 at the time of the event update. The stock was up Rs 81.85, or 2.20%, from the previous close of Rs 3,713.10.
Why is Ajanta Pharma Ltd. Share Price in focus today?
Ans. Ajanta Pharma Ltd. Share Price is in focus because the stock touched a fresh 52-week high of Rs 3,796.95 on 18 August 2026. The data confirms the price event, though no company-specific catalyst is established.
What was the fresh 52-week high for Ajanta Pharma Ltd.?
Ans. The fresh 52-week high for Ajanta Pharma Ltd. was Rs 3,796.95. The stock traded at Rs 3,794.95 around the event time, showing that Ajanta Pharma Ltd. Share Price remained close to the session peak.
How much did Ajanta Pharma Ltd. Share Price rise today?
Ans. Ajanta Pharma Ltd. Share Price rose by Rs 81.85 in today’s session, which translates to a gain of 2.20%. The move came from a previous close of Rs 3,713.10 to Rs 3,794.95.
What was the intraday range of Ajanta Pharma Ltd. stock?
Ans. Ajanta Pharma Ltd. stock traded between a day low of Rs 3,709.10 and a day high of Rs 3,796.95. It opened at Rs 3,713.50, indicating an almost flat start before moving higher intraday.
What is the market capitalisation of Ajanta Pharma Ltd.?
Ans. Ajanta Pharma Ltd. had a market capitalisation of Rs 45,924.32 crore in the supplied data. That is much higher than both the sector benchmark average of Rs 468.36 crore and median of Rs 136.28 crore.
What do the valuation ratios show for Ajanta Pharma Ltd.?
Ans. The supplied valuation ratios show a P/E of 170.32 and a P/B of 0.42 for Ajanta Pharma Ltd. Compared with the healthcare benchmark, the P/E is above average while the P/B is below average.
How does Ajanta Pharma Ltd. compare with the healthcare sector benchmark?
Ans. Ajanta Pharma Ltd. has a P/E of 170.32 versus the sector median of 21 and average of 49.19. Its P/B of 0.42 is below the sector median 1.9 and average 2.6.
What do ROE and ROCE indicate for Ajanta Pharma Ltd.?
Ans. The supplied profitability ratios show ROE at -2.89% and ROCE at -0.26% for Ajanta Pharma Ltd. Both are below the healthcare sector medians of 10.92% for ROE and 13.29% for ROCE.
Where can investors track Ajanta Pharma Ltd. Share Price updates?
Ans. Investors can track Ajanta Pharma Ltd. Share Price on Univest for live price moves, 52-week levels, valuation ratios, market-cap data and broader stock analysis. That helps place daily price action in a structured market context.
